Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated October 01, 2024, titled "Press Release Sun Pharma and Philogen enter into a global Exclusive Commercialization, License, and Supply Agreement for Commercializing the specialty product FIBROMUN".